Description

Ingredion’s $5 Billion Tate & Lyle Takeover Could Be A Specialty Ingredients Shift!

Ingredion has entered a major new chapter with its recommended all-cash offer to acquire Tate & Lyle, a transaction valuing the U.K.-based ingredients specialist at an enterprise value of roughly £3.7 billion, or about $5 billion. The move follows Ingredion’s multi-year push to shift its portfolio away from traditional ingredients and toward higher-value specialty solutions focused on texture, sugar reduction, nutrition, and formulation support. Tate & Lyle brings around $2.7 billion in fiscal 2026 revenue, about $570 million in adjusted EBITDA, nearly 5,000 employees, and a patent portfolio of roughly 1,000. On a combined basis, management expects the group to generate about $10 billion in revenue and $1.8 billion in adjusted EBITDA before integration and synergies. The deal is expected to be more than 15% adjusted EPS accretive in the first full calendar year after closing, while still requiring shareholder and regulatory approvals.